ASLE
AerSale Corporation
ASLE offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has the edge over ASLE overall, supported by stronger fundamentals and stronger modeled upside.
ASLE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Weak |
ASLE's revenue is currently stable, but its profitability, cash flow and balance sheet are weak.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
ASLE PE Valuation
ASLE has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
ASLE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect ASLE's earnings and profitability to decline, with its revenue holding steady.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over ASLE on the outlook, with more favorable earnings and revenue expectations.
ASLE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.27 | — |
| Q3 2026 | -$0.40 | -408% |
| Q2 2026 | -$0.09 | -164% |
| Q1 2026 | $0.21 | +$0.32 |
| Q4 2025 | $0.18 | +64% |
| Q3 2025 | $0.13 | +$0.14 |
| Q2 2025 | $0.14 | +$0.16 |
| Q1 2025 | -$0.11 | -$0.08 |
| Q4 2024 | $0.11 | +$0.26 |
ASLE has swung to a loss: it lost $0.40 per share over the past year, after a profit the year before.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over ASLE on earnings quality, reporting a profit while its opponent remains loss making.
ASLE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $91.6M | +29% |
| Q2 2026 | $70.9M | -34% |
| Q1 2026 | $70.6M | +7.4% |
| Q4 2025 | $90.9M | -4% |
| Q3 2025 | $71.2M | -14% |
| Q2 2025 | $107.4M | +39% |
| Q1 2025 | $65.8M | -27% |
| Q4 2024 | $94.7M | +0.3% |
ASLE's revenue is recovering but still below its 2022 peak: $92M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | -17 points |
| Q2 2026 | -6.7% | -18 points |
| Q1 2026 | -4.7% | +5.4 points |
| Q4 2025 | 7.8% | +2.5 points |
| Q3 2025 | 4% | +1.6 points |
| Q2 2025 | 12% | +14 points |
| Q1 2025 | -10% | -15 points |
| Q4 2024 | 5.2% | +6.3 points |
ASLE's operating margin was −13% last quarter, down 17 points from the same quarter a year ago, near the bottom of its range since 2021.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over ASLE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over ASLE on profitability, with a higher operating margin.
ASLE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.1M | -$1.3M |
| Q2 2026 | -$7.6M | -141% |
| Q1 2026 | -$27.7M | +$19.9M |
| Q4 2025 | $9.8M | -70% |
| Q3 2025 | -$9.8M | -211% |
| Q2 2025 | $18.6M | +$37.6M |
| Q1 2025 | -$47.6M | -$22.6M |
| Q4 2024 | $32.3M | +$41.9M |
ASLE has burned cash in most quarters: −$37M over the past year, against −$7M the year before.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over ASLE on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASLE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +377K shares |
| 1 year | +1.2% | +544K shares |
| 3 years | -7% | -3.6M shares |
| 5 years | +12% | +5.1M shares |
ASLE has 48M diluted shares, up 1.2% from a year ago.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over ASLE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
ASLE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 15.1x | High |
| Q2 2026 | 6.2x | High |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.1x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 7.8x | High |
| Q4 2024 | 1.4x | Healthy |
ASLE's net debt is about 15 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over ASLE on leverage, with a lower net debt burden relative to earnings.
ASLE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 20.4 | Neutral |
ASLE's weekly RSI is 42 (neutral) and its Stochastic is 20 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ASLE PE vs Industrials Sector
| Metric | ASLE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ASLE has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
ASLE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.94 | 4% above |
| 20 week MA | $5.51 | 6.7% below |
| 50 week MA | $6.30 | 18% below |
| 100 week MA | $6.63 | 22% below |
| 200 week MA | $8.96 | 43% below |
ASLE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 43% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over ASLE on trend strength, trading above more of its moving averages.
ASLE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.2 | $11.9 | +17% |
| 2021 | $11.9 | $17.3 | +46% |
| 2022 | $17.3 | $15.4 | -11% |
| 2023 | $15.4 | $12.7 | -17% |
| 2024 | $12.7 | $6.13 | -52% |
| 2025 | $6.13 | $7.11 | +16% |
| 2026 YTD | $7.11 | $5.14 | -28% |
ASLE has finished lower in three of the last six years. It's down 28% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over ASLE on returns for 2026, with the stronger performance.